Efficacy and safety of ultra-low dose inhaled melphalan in the treatment of hospitalized patients with COVID-19
Background. One of the most important components of COVID-19 therapy is the suppression of the hyperergic immune response. There is an urgent need of creating the optimal tactics of efficient and safe anti-inflammatory therapy. A new method of treatment of COVID-19 with inhalation of ultra-low (non-...
Main Authors: | E. A. Sinitsyn, A. A. Zykova, R. V. Shamin, A. V. Rvacheva, A. O. Bogatyreva, T. V. Shapovalenko, G. G. Maryin, K. A. Zykov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Scientific Сentre for Family Health and Human Reproduction Problems
2022-05-01
|
Series: | Acta Biomedica Scientifica |
Subjects: | |
Online Access: | https://www.actabiomedica.ru/jour/article/view/3408 |
Similar Items
-
Clinical and pathomorphological changes in the rabbit retina after an injection of various doses of the cytostatic melphalan
by: N. F. Bobrova, et al.
Published: (2023-11-01) -
Current and Novel Alkylators in Multiple Myeloma
by: Fredrik Schjesvold, et al.
Published: (2021-05-01) -
A complex case of necrobiotic xanthogranuloma with IgG‐kappa paraproteinemia: Disease regression achieved with melphalan and prednisone combination therapy
by: Jacques A. J. Malherbe, et al.
Published: (2022-11-01) -
Ultrastructural changes in the rabbit retina after various one-time doses of intravitreal melphalan
by: N.F. Bobrova, et al.
Published: (2020-08-01) -
Melphalan intra-arterial chemotherapy for choroidal melanoma chemoreduction
by: Rodrigo Jorge, et al.
Published: (2022-08-01)